| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Alaunos Therapeutics, Inc.
13D/A
TCRT · 98973P309
|
10.0% |
10/15/2026
Event 10/13/2026
|
||||
| WaterMill Asset Management Corp. | 10.0% | |||||
| Postma Robert W | 10.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.